Logo
Secure Registration

International Conference on Vaccines, Infectious Diseases and Immunological Research

ICVIDIR

15th Feb – 16th Feb 2027 Kyoto, Japan

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 16
01 Advancements in Vaccine Development +
This track focuses on the latest innovations in vaccine technology, including novel adjuvants and delivery systems. Researchers will present findings on the efficacy and safety of new vaccine candidates against various infectious diseases.
SDG 3 SDG 4
02 Immunological Mechanisms in Infectious Diseases +
This session will explore the underlying immunological responses to infectious agents, highlighting the role of innate and adaptive immunity. Presentations will cover mechanisms of immune evasion by pathogens and implications for vaccine design.
SDG 3 SDG 4
03 Clinical Trials in Vaccine Research +
This track will discuss the design, implementation, and outcomes of clinical trials for new vaccines. Attendees will gain insights into regulatory challenges and the importance of diverse populations in trial participation.
SDG 3 SDG 9
04 Pathogen Biology and Host Interactions +
This session will delve into the biology of pathogens and their interactions with the host immune system. Research presented will include studies on virulence factors and their impact on disease progression.
SDG 3 SDG 4
05 Outbreak Control and Public Health Strategies +
This track will examine strategies for controlling infectious disease outbreaks, including vaccination campaigns and public health interventions. Case studies will highlight successful responses to recent outbreaks.
SDG 3 SDG 17
06 Immunotherapy for Infectious Diseases +
This session will focus on the role of immunotherapy in treating infectious diseases, including monoclonal antibodies and immune checkpoint inhibitors. Discussions will cover current research and future directions in this emerging field.
SDG 3 SDG 9
07 Vaccine Hesitancy and Public Perception +
This track will address the challenges of vaccine hesitancy and its impact on public health. Researchers will present studies on factors influencing vaccine acceptance and strategies to improve public perception.
SDG 3 SDG 16
08 Emerging Infectious Diseases and Global Health +
This session will focus on the emergence of new infectious diseases and their implications for global health security. Presentations will include surveillance strategies and the role of international collaboration in outbreak response.
SDG 3 SDG 17
09 Novel Approaches to Disease Prevention +
This track will explore innovative strategies for disease prevention beyond vaccination, including behavioral interventions and public health policies. Research will highlight the importance of a multidisciplinary approach to health promotion.
SDG 3 SDG 4
10 Vaccine Safety and Pharmacovigilance +
This session will discuss the importance of vaccine safety monitoring and pharmacovigilance in ensuring public trust. Presentations will cover methodologies for assessing vaccine safety and reporting adverse events.
SDG 3 SDG 16
11 Global Collaboration in Vaccine Research +
This track will highlight the significance of international partnerships in advancing vaccine research and development. Discussions will focus on collaborative efforts to address global health challenges and share resources.
SDG 17 SDG 3